Martin Sean
SEC CIK 1500332 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BAX | Baxter International | SVP, GC | 52.6K | — | $3.24M | 7 | 2021-08-02 | 2022-03-02 |
Most active insiders at BAX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Teaff James | Pres, CCS | — | — |
| 2 | Foster Julie | Pres, Front Line Care | — | — |
| 3 | Soriano Maria Cecilia | Group Pres, ITT, Pharma | — | — |
| 4 | Carlisle Cynthia | EVP, CHRO | — | — |
| 5 | Ampofo William A. II | Dir | — | — |
| 6 | Rasul Reazur | EVP, Group Pres, Healthcare | — | — |
| 7 | Hider Andrew P. | Pres, CEO, Dir | — | — |
| 8 | Rosenbloom David S. | EVP, GC | — | — |
| 9 | Wilkes David S. | Dir | — | — |
| 10 | Wallace Steven P. | Pres, Adv. Surgery | — | — |
Martin Sean made no open-market trades at BAX in the last 12 months.
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-04 | 2022-03-02 | BAX | Baxter International | Martin Sean | SVP, GC | A - Grant | $0.00 | +6,688 | 52.6K | +15% | $0 |
| M | 2022-02-14 | 2022-02-10 | BAX | Baxter International | Martin Sean | SVP, GC | A - Grant | $0.00 | +6,240 | 48.6K | +15% | $0 |
| 2022-02-14 | 2022-02-10 | BAX | Baxter International | Martin Sean | SVP, GC | F - Tax | $87.75 | -2,675 | 45.9K | -6% | -$234.7K | |
| DM | 2021-11-03 | 2021-11-01 | BAX | Baxter International | Martin Sean | SVP, GC | S - Sale+OE | $79.57 | -21.4K | 43.9K | -33% | -$1.71M |
| D | 2021-11-03 | 2021-11-01 | BAX | Baxter International | Martin Sean | SVP, GC | M - OptEx | $50.77 | +21.4K | 63.7K | +51% | +$1.09M |
| D | 2021-08-04 | 2021-08-02 | BAX | Baxter International | Martin Sean | SVP, GC | S - Sale+OE | $77.26 | -19.8K | 42.2K | -32% | -$1.53M |
| D | 2021-08-04 | 2021-08-02 | BAX | Baxter International | Martin Sean | SVP, GC | M - OptEx | $50.77 | +19.8K | 62.0K | +47% | +$1.01M |
Purchase Sale Sale after option exercise All abbreviations